Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00349011 · ClinicalTrials.gov registry record · NA
Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00349011 is a NA study that has completed, run by Yale University. The registered enrollment target is 60 participants.
The verdict
NCT00349011, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of a personalized menopausal therapy risk assessment and genetic counseling intervention on knowledge, risk perception, and decision-making in healthy women at increased risk for breast cancer.
Interventions
- PROCEDURE Personalized risk assessment
- PROCEDURE genetic counseling intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2002-08 |
| Est. Completion | 2004-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00349011
The ClinicalTrials.gov registry entry for NCT00349011 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Personalized risk assessment is the first listed.
NCT00349011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00349011 about?
NCT00349011 is a clinical study titled "Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer". The purpose of this study is to determine the effects of a personalized menopausal therapy risk assessment and genetic counseling intervention on knowledge, risk perception, and decision-making in healthy women at increased risk for breast cancer.
What is the current status of trial NCT00349011?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2002-08. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00349011?
The interventions under investigation include: Personalized risk assessment (PROCEDURE), genetic counseling intervention (PROCEDURE).
Who is sponsoring clinical trial NCT00349011?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.